NCT00938171

Brief Summary

The purpose of this study is to determine therapeutic benefits by local anesthetic technique for breast cancer.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at below P25 for phase_3 breast-cancer

Timeline
Completed

Started Jun 2008

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2008

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

July 10, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 13, 2009

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
Last Updated

July 13, 2009

Status Verified

July 1, 2009

Enrollment Period

3.1 years

First QC Date

July 10, 2009

Last Update Submit

July 10, 2009

Conditions

Keywords

CytokineAnesthesiaLocal anesthesiasurgerybreast cancer

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale (VAS) pain scores

    Until PACU discharge and for 24 hours

Secondary Outcomes (4)

  • disease free survival

    5 years

  • Episodes of nausea or vomiting

    24 hours

  • Overall patient satisfaction

    After hospital discharge and six months later

  • The need for postoperative opioids

    24 hours

Study Arms (2)

local anesthesia

ACTIVE COMPARATOR

local anesthesia with propofol sedation Target-controlled infusion (TCI) system will be used to maintain proper sedation level)

Procedure: Local anesthesia

General anesthesia

ACTIVE COMPARATOR

Patients receiving general anesthesia

Procedure: General anesthesia

Interventions

All patients will be then given adequate sedation with propofol and local anesthetic given by dermal infiltration in incision site and regional breast and axillary areas. The local anesthetic of choice will be 2 % lidocaine (Xylocaine) and 0.5% Bupivacaine (Marcaine) mixed with 7 % sodium bicarbonate and epinephrine (Bosmine)

Also known as: LA
local anesthesia

The method of general anesthesia for the GA group will be induced with fentanyl (1-2 μg/kg) and propofol (2.5 mg/kg). After placement of a laryngeal mask or endotracheal tube airway, anesthesia will be maintained with sevoflurane (end-tidal concentrations 1%-3%) in a 50% oxygen/nitrous oxide mixture.

Also known as: GA
General anesthesia

Eligibility Criteria

Age21 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Biopsy-proven breast cancer Scheduled for mastectomy and axillary node dissection in a single procedure.

You may not qualify if:

  • previous surgery within the preceding 2 wk those other than ASA physical status I or II any contraindication to either local anesthesia or opioid analgesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mackay memorial hospital

Taipei, 10449, Taiwan

RECRUITING

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Anesthesia, LocalAnesthesia, General

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Study Officials

  • YuanChing Chang, MD

    Mackay Memorial Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yuan-Ching Chang, MD

CONTACT

Yuan-Ching Chang, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 10, 2009

First Posted

July 13, 2009

Study Start

June 1, 2008

Primary Completion

July 1, 2011

Study Completion

July 1, 2013

Last Updated

July 13, 2009

Record last verified: 2009-07

Locations